[Clinical evaluation of Hespander].
D000328:Adult; D000368:Aged; D000771:Anesthesia, Intravenous; D001809:Blood Viscosity / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D003911:Dextrans / Q000494:pharmacology; D000431:Ethanol / Q000009:adverse effects / Q000494:pharmacology; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010952:Plasma Substitutes; D011863:Radioimmunoassay; D013213:Starch / Q000009:adverse effects; D013312:Stress, Physiological / Q000097:blood*; D013514:Surgical Procedures, Operative; D013997:Time Factors
D003911:Dextrans; D010952:Plasma Substitutes; D000431:Ethanol; D013213:Starch